Jump to navigation
NDRI is leading a clinical trial to establish whether a new medication can help people reduce their ice use.
Researchers from the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney are reaching out to young people who participated in a landmark 2012 trial to assess the long-term impact of school-based drug and alcohol prevention programs.
A new email newsletter will share news and research findings from the Drug Trends Team at NDARC.
As part of the Australian Indigenous AOD Knowledge Centre’s ongoing webinar series, NCETA’s Associate Professor Ken Pidd will present a webinar on drug testing on 9 May 2018.
More than three quarters of people who develop dependence on codeine do not seek help despite highly effective treatments being available, says NDARC's Dr Suzanne Nielsen.
A naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures, suggests a review of the available evidence by researchers at NDARC.
New South Wales (NSW) smokers who want to quit are being recruited to take part in a world first trial comparing two smoking cessation medications – a natural plant extract, cytisine, and the presc
NDRI's Steve Allsop and Tanya Chikritzhs were among a select group of invited speakers at the recent WA health summit.
Professor Ann Roche presented on the patterns and prevalence of AOD use in rural Australia at the 6th Rural and Remote Health Scientific Symposium on 11 April, 2018.
NDARC regularly hosts free seminars on a range of topics in the alcohol and other drug (AOD) field.
NDRI made a significant contribution to the 2018 WA AOD Conference, a key event for the sector in Western Australia.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Wednesday 15 August 2018